MK-0736

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK-0736, covering 2015-02-16 to 2015-02-16. Get the full timeline:

Most recent: Clinical Trial Update: A Study of How MK-0736 Affects Arterial Plaque (0736-006)(TERMINATED) [Phase 1]